4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-21-059984
COO & Chief Financial Officer sold 4,963 shares at $98.50 ($488,856)
- COO & Chief Financial Officer acquired 4,963 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LOWE CHRISTOPHER P. COO & Chief Financial Officer | 2021-10-05 | Option exercise | +4,963 | $54.85 | $272,221 | 64,963 | D: show line 1 in the form |
| LOWE CHRISTOPHER P. COO & Chief Financial Officer | 2021-10-05 | Sale | −4,963 | $98.50 | $488,856 | 60,000 | D: show line 2 in the form |
| Open-market sales · 4,963 sh · avg $98.50 · $488,856 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| LOWE CHRISTOPHER P. COO & Chief Financial Officer | 2021-10-05 | Option exercise · Stock Option (Right to Buy) | −4,963 | 95,037 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…